Early Insights into Biosimilar Cost Savings in the United States
A recent study inJAMA Oncologyexamined the average daily cost of biosimilar filgrastim-sndz compared with the brand name biologic.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news